Caas Capital Management LP Stryker Corp Put Options Transaction History

Caas Capital Management LP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 Apr 26, 2024	SELL	$293.94 - $358.71 $117,576 - $143,484	-400 Reduced 18.18%	1,800 $644,000
Q4 2023 Feb 14, 2024	BUY	$253.85 - $299.46 $558,470 - $658,812	2,200 New	2,200 $658,000
Q1 2023 May 15, 2023	SELL	$246.13 - $285.47 $270,743 - $314,017	-1,100 Reduced 33.33%	2,200 $628,000
Q4 2022 Feb 14, 2023	BUY	$205.51 - $253.93 $678,183 - $837,969	3,300 New	3,300 $806,000
Q2 2021 Aug 16, 2021	SELL	$242.95 - $267.0 $728,850 - $801,000	-3,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$221.01 - $248.82 $663,030 - $746,460	3,000 New	3,000 $731,000

2,228

285M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $148B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.